These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 458281)

  • 1. Electrocardiographic observations on the termination of supraventricular tachycardia by verapamil.
    Feigl D; Ravid M
    J Electrocardiol; 1979; 12(2):129-36. PubMed ID: 458281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome.
    Hamer A; Peter T; Platt M; Mandel WJ
    Am Heart J; 1981 May; 101(5):600-12. PubMed ID: 7223599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of verapamil on retrograde conduction in atrioventricular nodal reentrant tachycardia.
    Reddy CP; McAllister RG
    Am J Cardiol; 1984 Sep; 54(6):535-43. PubMed ID: 6475770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous adenosine triphosphate during wide QRS complex tachycardia: safety, therapeutic efficacy, and diagnostic utility.
    Sharma AD; Klein GJ; Yee R
    Am J Med; 1990 Apr; 88(4):337-43. PubMed ID: 2327421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic characteristics of wide QRS complexes during pharmacologic termination of sustained supraventricular tachycardias with verapamil and adenosine: observations from electrophysiologic study.
    Türkoğlu C; Oztürk M; Aliyev F; Firatli I; Incesoy N
    Ann Noninvasive Electrocardiol; 2009 Oct; 14(4):375-80. PubMed ID: 19804515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wide complex tachycardia: misdiagnosis and outcome after emergent therapy.
    Stewart RB; Bardy GH; Greene HL
    Ann Intern Med; 1986 Jun; 104(6):766-71. PubMed ID: 3706928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil in the treatment of ventricular tachycardia.
    Sternbach G; Eliastam M
    Am J Emerg Med; 1985 Nov; 3(6):536-40. PubMed ID: 4063021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cycle length alternation in supraventricular tachycardia after administration of verapamil.
    Vohra J; Hunt D; Stuckey J; Sloman G
    Br Heart J; 1974 Jun; 36(6):570-6. PubMed ID: 4851237
    [No Abstract]   [Full Text] [Related]  

  • 9. [Verapamil in the study and treatment of supraventricular tachycardias, with special reference to pre-excitation].
    Krikler DM
    Minerva Med; 1975 May; 66(39):1914-22. PubMed ID: 236526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
    Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
    Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram.
    Heng MK; Singh BN; Roche AH; Norris RM; Mercer CJ
    Am Heart J; 1975 Oct; 90(4):487-98. PubMed ID: 1163442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine: a clinical experience and comparison with verapamil for the termination of supraventricular tachycardias.
    Sellers TD; Kirchhoffer JB; Modesto TA
    Prog Clin Biol Res; 1987; 230():283-99. PubMed ID: 3295883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misuse of intravenous verapamil in patients with ventricular tachycardia.
    Rankin AC; Rae AP; Cobbe SM
    Lancet; 1987 Aug; 2(8557):472-4. PubMed ID: 2887775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
    Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of adenosine and verapamil for the treatment of supraventricular tachycardia in the prehospital setting.
    Madsen CD; Pointer JE; Lynch TG
    Ann Emerg Med; 1995 May; 25(5):649-55. PubMed ID: 7741343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supraventricular tachyarrhythmias and rate-related hypotension: cardiovascular effects and efficacy of intravenous verapamil.
    Haynes BE; Niemann JT; Haynes KS
    Ann Emerg Med; 1990 Aug; 19(8):861-4. PubMed ID: 2372167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil in ventricular tachycardia.
    Hasin Y; Kriwisky M; Gotsman MS
    Cardiology; 1984; 71(4):199-206. PubMed ID: 6478466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrocardiographic observations on the termination of supraventricular tachycardia by verapamil].
    Xu JM
    Zhonghua Xin Xue Guan Bing Za Zhi; 1982 Jun; 10(2):100-3. PubMed ID: 7128437
    [No Abstract]   [Full Text] [Related]  

  • 19. Ventricular tachycardia induced by atrial stimulation in patients without symptomatic cardiac disease.
    German LD; Packer DL; Bardy GH; Gallagher JJ
    Am J Cardiol; 1983 Dec; 52(10):1202-7. PubMed ID: 6650408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective termination of reentrant supraventricular tachycardia by single dose oral combination therapy with pindolol and verapamil.
    Rose JS; Bhandari A; Rahimtoola SH; Wu D
    Am Heart J; 1986 Oct; 112(4):759-65. PubMed ID: 3766376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.